HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Circulating levels of asymmetric dimethylarginine are an independent risk factor for left ventricular hypertrophy and predict cardiovascular events in pre-dialysis patients with chronic kidney disease.

AbstractBACKGROUND:
Several studies have related the circulating level of asymmetric dimethylarginine (ADMA) to cardiac remodeling and cardiovascular (CV) events in end-stage renal disease (ESRD) patients. Studies investigating this relationship in patients with pre-dialysis chronic kidney disease (CKD) are lacking.
METHODS:
We enrolled 76 CKD patients (age, 46.7+/-14.3 years, 39 females) and 15 controls (age, 40.1+/-18.5 years, 6 females). Clinical parameters, blood biochemistry and echocardiographic findings were recorded, and plasma ADMA concentrations measured by high-performance liquid chromatography-mass spectrometry (HPLC-MS). Patients were prospectively followed up for a median of 15 (range, 6-24) months.
RESULTS:
Plasma ADMA was significantly elevated in CKD patients compared with controls (41.56+/-12.76 microg/mL vs 17.12+/-7.09 microg/mL, P<0.001), and correlated with the left ventricular mass index (LVMI) (r=0.597, P<0.001). During follow-up, 25 patients experienced new CV events and their plasma ADMA level was significantly elevated (48.27+/-13.70 vs 34.91+/-6.38 in CV event-free patients, P<0.001). Cox regression analysis further confirmed that ADMA was an independent risk factor for CVD (HR=1.175, 95%CI[1.070-1.290], P=0.001).
CONCLUSION:
Similar to findings in ESRD patients, elevated circulating levels of ADMA may increase the risk of LVH and CV events in pre-dialysis CKD patients.
AuthorsBeili Shi, Zhaohui Ni, Wenyan Zhou, Zanzhe Yu, Leyi Gu, Shan Mou, Wei Fang, Qin Wang, Liou Cao, Yucheng Yan, Jiaqi Qian
JournalEuropean journal of internal medicine (Eur J Intern Med) Vol. 21 Issue 5 Pg. 444-8 (Oct 2010) ISSN: 1879-0828 [Electronic] Netherlands
PMID20816602 (Publication Type: Journal Article)
CopyrightCopyright (c) 2010 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
Chemical References
  • N,N-dimethylarginine
  • Arginine
Topics
  • Adult
  • Arginine (analogs & derivatives, blood)
  • Female
  • Follow-Up Studies
  • Humans
  • Hypertrophy, Left Ventricular (blood, epidemiology)
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Predictive Value of Tests
  • Prospective Studies
  • Renal Dialysis
  • Renal Insufficiency, Chronic (blood, epidemiology)
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: